| Broad-spectrum non-toxic antiviral nanoparticles with a virucidal inhibition mechanism V Cagno, P Andreozzi, M D’Alicarnasso, P Jacob Silva, M Mueller, ... Nature materials 17 (2), 195-203, 2018 | 395 | 2018 |
| Heparan sulfate proteoglycans and viral attachment: true receptors or adaptation bias? V Cagno, ED Tseligka, ST Jones, C Tapparel Viruses 11 (7), 596, 2019 | 326 | 2019 |
| Modified cyclodextrins as broad-spectrum antivirals ST Jones, V Cagno, M Janeček, D Ortiz, N Gasilova, J Piret, M Gasbarri, ... Science advances 6 (5), eaax9318, 2020 | 157 | 2020 |
| Propagation of respiratory viruses in human airway epithelia reveals persistent virus-specific signatures M Essaidi-Laziosi, F Brito, S Benaoudia, L Royston, V Cagno, ... Journal of Allergy and Clinical Immunology 141 (6), 2074-2084, 2018 | 117 | 2018 |
| Additives for vaccine storage to improve thermal stability of adenoviruses from hours to months M Pelliccia, P Andreozzi, J Paulose, M D’Alicarnasso, V Cagno, ... Nature communications 7 (1), 13520, 2016 | 109 | 2016 |
| Inhibition of pathogenic non-enveloped viruses by 25-hydroxycholesterol and 27-hydroxycholesterol A Civra, V Cagno, M Donalisio, F Biasi, G Leonarduzzi, G Poli, D Lembo Scientific reports 4 (1), 7487, 2014 | 102 | 2014 |
| Oxysterols: An emerging class of broad spectrum antiviral effectors D Lembo, V Cagno, A Civra, G Poli Molecular Aspects of Medicine 49, 23-30, 2016 | 90 | 2016 |
| Preparation, characterization and in vitro antiviral activity evaluation of foscarnet-chitosan nanoparticles E Russo, N Gaglianone, S Baldassari, B Parodi, S Cafaggi, C Zibana, ... Colloids and Surfaces B: Biointerfaces 118, 117-125, 2014 | 70 | 2014 |
| A high-throughput cell-and virus-free assay shows reduced neutralization of SARS-CoV-2 variants by COVID-19 convalescent plasma C Fenwick, P Turelli, C Pellaton, A Farina, J Campos, C Raclot, F Pojer, ... Science Translational Medicine 13 (605), eabi8452, 2021 | 66 | 2021 |
| 25-Hydroxycholesterol and 27-hydroxycholesterol inhibit human rotavirus infection by sequestering viral particles into late endosomes A Civra, R Francese, P Gamba, G Testa, V Cagno, G Poli, D Lembo Redox biology 19, 318-330, 2018 | 65 | 2018 |
| In vitro anti-Herpes simplex virus activity of crude extract of the roots of Nauclea latifolia Smith (Rubiaceae) M Donalisio, HM Nana, RA Ngono Ngane, D Gatsing, A Tiabou Tchinda, ... BMC complementary and alternative medicine 13, 1-8, 2013 | 63 | 2013 |
| SARS-CoV-2 cellular tropism V Cagno The Lancet Microbe 1 (1), e2-e3, 2020 | 62 | 2020 |
| Inhibition of human respiratory syncytial virus infectivity by a dendrimeric heparan sulfate-binding peptide M Donalisio, M Rusnati, V Cagno, A Civra, A Bugatti, A Giuliani, G Pirri, ... Antimicrobial agents and chemotherapy 56 (10), 5278-5288, 2012 | 61 | 2012 |
| A VP1 mutation acquired during an enterovirus 71 disseminated infection confers heparan sulfate binding ability and modulates ex vivo tropism ED Tseligka, K Sobo, L Stoppini, V Cagno, F Abdul, I Piuz, P Meylan, ... PLoS pathogens 14 (8), e1007190, 2018 | 60 | 2018 |
| Inhibition of herpes simplex-1 virus replication by 25-hydroxycholesterol and 27-hydroxycholesterol V Cagno, A Civra, D Rossin, S Calfapietra, C Caccia, V Leoni, N Dorma, ... Redox Biology 12, 522-527, 2017 | 58 | 2017 |
| Do we need a contact tracing app? L Maccari, V Cagno Computer Communications 166, 9-18, 2021 | 57 | 2021 |
| In vitro evaluation of the antiviral properties of Shilajit and investigation of its mechanisms of action V Cagno, M Donalisio, A Civra, C Cagliero, P Rubiolo, D Lembo Journal of ethnopharmacology 166, 129-134, 2015 | 51 | 2015 |
| The tyrosine kinase inhibitor nilotinib inhibits SARS‐CoV‐2 in vitro V Cagno, G Magliocco, C Tapparel, Y Daali Basic & clinical pharmacology & toxicology 128 (4), 621-624, 2021 | 45 | 2021 |
| Auto-associative heparin nanoassemblies: a biomimetic platform against the heparan sulfate-dependent viruses HSV-1, HSV-2, HPV-16 and RSV D Lembo, M Donalisio, C Laine, V Cagno, A Civra, EP Bianchini, ... European Journal of Pharmaceutics and Biopharmaceutics 88 (1), 275-282, 2014 | 45 | 2014 |
| Highly sulfated K5 Escherichia coli polysaccharide derivatives inhibit respiratory syncytial virus infectivity in cell lines and human tracheal-bronchial histocultures V Cagno, M Donalisio, A Civra, M Volante, E Veccelli, P Oreste, M Rusnati, ... Antimicrobial agents and chemotherapy 58 (8), 4782-4794, 2014 | 40 | 2014 |
Caroline Tapparel VuDepartment of microbiology and molecular medicine, Faculty of Medicine, univerisity of GenevaVerified email at unige.ch
